Baxter International (BAX) vs Stevanato Group S.p.A. (STVN)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Baxter International (BAX) has outperformed Stevanato Group S.p.A. (STVN) over the past year, gaining 4.7% versus a loss of 19.2%. Over five years, STVN leads with a -20.1% price change compared with -69.9% for BAX. Baxter International is the larger company by market cap ($12.36 billion vs $5.25 billion), about 2.4 times the size.
On valuation, Baxter International trades at a lower forward P/E (11.7x vs 23.0x for Stevanato Group S.p.A.). Baxter International pays a dividend yielding 0.84%, while Stevanato Group S.p.A. does not currently pay one.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | BAX | STVN |
|---|---|---|
| Share price | $23.90 | $19.21 |
| Market cap | $12.36B | $5.25B |
| 1-day change | -0.29% | -1.18% |
| YTD return | +25.43% | -3.38% |
| 1-year return | +4.67% | -19.20% |
| 5-year return | -69.92% | -20.07% |
| P/E ratio (TTM) | — | 33.70 |
| Forward P/E | 11.72 | 23.02 |
| EPS (TTM) | $-1.88 | $0.57 |
| Dividend yield | 0.84% | 0.32% |
| Annual dividend | $0.20 | $0.00 |
| Revenue (latest FY) | $11.24B | — |
| Revenue growth (YoY) | +5.72% | — |
| Net income (latest FY) | $-957.00M | — |
| Gross margin | 30.05% | — |
| Operating margin | -2.74% | — |
| Net margin | -8.51% | — |
| 52-week high | $30.00 | $27.99 |
| 52-week low | $15.73 | $12.89 |
| Distance from 52-week high | -20.33% | -31.37% |
| Analyst consensus | hold | buy |
| Avg. price target upside | +16.82% | +28.47% |
| Average volume | 6.60M | 370.27K |
| Shares outstanding | 517.00M | 49.83M |
| Employees | 37,500 | 6,010 |
| Sector | Health Care | Health Care |
| Industry | Medical/Dental Instruments | Medical/Dental Instruments |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Baxter International is about 2.4 times larger than Stevanato Group S.p.A. by market value ($12.36B vs $5.25B).
- BAX has outperformed STVN by 23.9 percentage points over the past year.
About Baxter International
BAX stock →Baxter International Inc., through its subsidiaries, provides a portfolio of healthcare products in the United States. The company operates through three segments: Medical Products & Therapies, Healthcare Systems & Technologies, and Pharmaceuticals.
Health Care · Medical/Dental Instruments · 37,500 employees
About Stevanato Group S.p.A.
STVN stock →Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide solutions for biopharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific.
Health Care · Medical/Dental Instruments · 6,010 employees
BAX vs STVN FAQ
Which is bigger, Baxter International or Stevanato Group S.p.A.?
Baxter International (BAX) is larger, with a market capitalization of $12.36B compared with $5.25B for Stevanato Group S.p.A. (STVN).
Which stock has performed better over the past year, BAX or STVN?
BAX returned +4.67% over the past 12 months, compared with -19.20% for STVN (price return, excluding dividends). Past performance does not predict future results.
Which pays a higher dividend, Baxter International or Stevanato Group S.p.A.?
Baxter International has the higher yield at 0.84%, compared with 0.32% for Stevanato Group S.p.A..
Are Baxter International and Stevanato Group S.p.A. in the same industry?
Yes. Both are classified in the Medical/Dental Instruments industry within the Health Care sector.